One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1016/j.jaad.2023.08.111
Copy DOI Publication Date: Oct 14, 2023 | |
 Citations: 2 |  License type: cc-by-nc-nd |
Affiliation: University of Florence, Hospital Universitario Virgen Macarena, Moffitt Cancer Center, Regeneron (United States), University of Barcelona, National and Kapodistrian University of Athens, Andreas Sygros Hospital, University of Ioannina, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Sanofi (United States), University of Colorado Denver, University of Colorado Anschutz Medical Campus, Mayo Clinic, Hôpital Saint-Louis, Kiel University, Stanford University, Istituti di Ricovero e Cura a Carattere Scientifico, Agostino Gemelli University Polyclinic, The University of Texas MD Anderson Cancer Center, University Medical Center of the Johannes Gutenberg University Mainz, Johannes Gutenberg University Mainz, University of Bordeaux, Charité - Universitätsmedizin Berlin, Hôpital Lyon Sud, KU Leuven, Institut Polytechnique de Paris, University of Paris-Saclay, Institut Gustave Roussy, Otto-von-Guericke University Magdeburg, Johannes Wesling Klinikum Minden, Ruhr University Bochum, University Hospital of ZurichPhase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
